Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated analogs of bioactive molecules. Its structure enables the introduction of a trifluoromethyl-substituted benzyl group, which can enhance metabolic stability and lipophilicity in drug candidates. Commonly employed in Horner-Wadsworth-Emmons reactions to form fluorinated olefins, which are important motifs in medicinal chemistry. Also utilized in agrochemical research for designing novel active ingredients with improved environmental stability and biological activity.